PolyPid Free Cash Flow Per Share vs End Period Cash Flow Analysis
| PYPD Stock | USD 2.87 0.05 1.77% |
PolyPid financial indicator trend analysis is much more than just breaking down PolyPid prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PolyPid is a good investment. Please check the relationship between PolyPid Free Cash Flow Per Share and its End Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
Free Cash Flow Per Share vs End Period Cash Flow
Free Cash Flow Per Share vs End Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PolyPid Free Cash Flow Per Share account and End Period Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between PolyPid's Free Cash Flow Per Share and End Period Cash Flow is -0.66. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of PolyPid, assuming nothing else is changed. The correlation between historical values of PolyPid's Free Cash Flow Per Share and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of PolyPid are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Free Cash Flow Per Share i.e., PolyPid's Free Cash Flow Per Share and End Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.66 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.End Period Cash Flow
Most indicators from PolyPid's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Enterprise Value is projected to decrease significantly based on the last few years of reporting.
PolyPid fundamental ratios Correlations
Click cells to compare fundamentals
PolyPid Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PolyPid fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Other Current Liab | 998K | 1.9M | 3.9M | 1.5M | 2.0M | 1.7M | |
| Total Current Liabilities | 2.6M | 2.9M | 7.8M | 8.6M | 7.3M | 4.0M | |
| Total Stockholder Equity | 30.9M | 72.8M | 36.2M | 5.9M | (2.1M) | (2.2M) | |
| Property Plant And Equipment Net | 6.1M | 5.9M | 8.8M | 11.7M | 9.2M | 5.3M | |
| Net Debt | (3.9M) | (4.3M) | (9.8M) | 5.2M | 6.2M | 6.5M | |
| Retained Earnings | (93.3M) | (132.3M) | (174.6M) | (214.4M) | (238.3M) | (226.4M) | |
| Accounts Payable | 1.6M | 974K | 4.1M | 1.1M | 772K | 1.3M | |
| Cash | 3.9M | 4.3M | 9.8M | 8.6M | 5.6M | 5.8M | |
| Non Current Assets Total | 6.4M | 28.3M | 9.4M | 11.8M | 9.3M | 7.8M | |
| Non Currrent Assets Other | 31K | 22.2M | 423K | 99K | 87K | 82.7K | |
| Other Assets | 230K | 22.8M | 663K | 99K | 113.9K | 108.2K | |
| Cash And Short Term Investments | 26.6M | 44.5M | 32.2M | 12.6M | 5.6M | 5.3M | |
| Net Receivables | 42K | (251K) | 118K | (213K) | (191.7K) | (182.1K) | |
| Liabilities And Stockholders Equity | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Non Current Liabilities Total | 251K | 193K | 199K | 11.5M | 10.2M | 9.7M | |
| Other Current Assets | 399K | 2.3M | 2.2M | 1.1M | 458K | 878.4K | |
| Other Stockholder Equity | 124.2M | 205.1M | 210.8M | 220.3M | 236.2M | 248.0M | |
| Total Liab | 2.8M | 3.1M | 8.0M | 20.1M | 17.5M | 24.1M | |
| Total Current Assets | 27.4M | 47.6M | 34.8M | 14.2M | 6.1M | 5.8M | |
| Accumulated Other Comprehensive Income | (766K) | (1.2M) | (106.4M) | (3.1M) | (2.8M) | (3.0M) | |
| Property Plant Equipment | 6.1M | 5.9M | 8.8M | 11.7M | 13.4M | 14.1M | |
| Other Liab | 251K | 193K | 199K | 2.8M | 3.3M | 3.4M | |
| Net Tangible Assets | (87.6M) | 72.8M | 36.2M | 5.8M | 6.7M | 7.0M | |
| Short Term Investments | 14.0M | 0.0 | 22.7M | 40.2M | 22.4M | 4.0M | |
| Non Current Liabilities Other | 251K | 193K | 199K | 174K | 398K | 273.2K | |
| Net Invested Capital | 30.9M | 72.8M | 36.2M | 17.5M | 8.3M | 8.7M | |
| Net Working Capital | 24.8M | 44.3M | 27.0M | 5.6M | (1.2M) | (1.2M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.22) | Return On Assets (0.65) | Return On Equity (4.97) |
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.